Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 851 to 900 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
851\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIAA1012\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
107.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
112.329\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04161\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HPRT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) (hgprt) (hgprtase). [source:swissprot;acc:p00492]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.114\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.412\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04154\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
853\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WDR33\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
108.289\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
112.772\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0414\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
854\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPSF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLEC3B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tetranectin precursor (tn) (plasminogen-kringle 4 binding protein). [source:swissprot;acc:p05452]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
178.514\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
XPR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
xenotropic and polytropic retrovirus receptor. [source:refseq;acc:nm\_004736]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.623\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04068\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PNO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0406\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STX12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 12. [source:refseq;acc:nm\_177424]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.997\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04043\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
859\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l39. [source:swissprot;acc:p02404]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
234.025\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.958\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04031\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
860\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s19. [source:swissprot;acc:p39019]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l31. [source:swissprot;acc:p12947]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
863\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK2A1P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
240.194\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03999\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
864\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK2A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BTF3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor btf3 (rna polymerase b transcription factor 3). [source:swissprot;acc:p20290]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.814\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03997\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
866\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRP68\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
signal recognition particle 68 kda protein (srp68). [source:swissprot;acc:q9uhb9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.306\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
867\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s3a. [source:swissprot;acc:p49241]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.674\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03981\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
868\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MVD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
diphosphomevalonate decarboxylase (ec 4.1.1.33) (mevalonate pyrophosphate decarboxylase) (mevalonate (diphospho)decarboxylase). [source:swissprot;acc:p53602]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.298\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.571\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03975\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
869\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exocyst complex component sec8. [source:swissprot;acc:q96a65]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.449\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03969\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
870\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.832\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPSF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
110.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
114.552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03949\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRPK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein k (hnrnp k) (dc-stretch binding protein) (csbp) (transformation upregulated nuclear protein) (tunp). [source:swissprot;acc:q07244]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.413\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
233.272\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03948\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
873\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRPF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
u4/u6 small nuclear ribonucleoprotein prp4 (u4/u6 snrnp 60 kda protein) (wd splicing factor prp4) (hprp4). [source:swissprot;acc:o43172]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-1 subunit (ampk gamma-1 chain) (ampkg). [source:swissprot;acc:p54619]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.002\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.954\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03946\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, catalytic alpha-2 chain (ec 2.7.1.-) (ampk alpha-2 chain). [source:swissprot;acc:p54646]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
876\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, catalytic alpha-1 chain (ec 2.7.1.-) (ampk alpha-1 chain). [source:swissprot;acc:q13131]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-1 subunit (ampk beta-1 chain) (ampkb). [source:swissprot;acc:q9y478]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-2 subunit (ampk gamma-2 chain) (ampk gamma2) (h91620p). [source:swissprot;acc:q9ugj0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYCL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYCN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n-myc proto-oncogene protein. [source:swissprot;acc:p04198]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03924\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
883\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GABPA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
227.596\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
219.017\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03917\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
884\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
885\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFS8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 23 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-23kd) (ci-23kd) (tyky subunit). [source:swissprot;acc:o00217]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
886\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELOVL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elongation of very long chain fatty acids protein 1 (cgi-88). [source:swissprot;acc:q9bw60]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
219.018\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
887\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transducin beta-like 3; wd-repeat protein sazd. [source:refseq;acc:nm\_006453]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
244.155\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03913\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
888\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.027\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03909\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
889\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.053\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03908\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STX7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 7. [source:swissprot;acc:o15400]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.012\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
891\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIRAS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.028\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
204.055\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03907\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
892\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIRAS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
di-ras2. [source:refseq;acc:nm\_017594]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
893\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myc proto-oncogene protein (c-myc). [source:swissprot;acc:p01106]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.585\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.037\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
894\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FARSA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase alpha chain (ec 6.1.1.20) (phenylalanine- -trna ligase alpha chain) (phers) (cml33). [source:swissprot;acc:q9y285]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.491\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.323\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03902\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
895\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phenylalanine-trna synthetase. [source:refseq;acc:nm\_006567]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
896\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR2J\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 13.3 kda polypeptide (ec 2.7.7.6) (rpb11). [source:swissprot;acc:p52435]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
239.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03888\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDPK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3-phosphoinositide dependent protein kinase-1 (ec 2.7.1.37) (hpdk1). [source:swissprot;acc:o15530]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
272.878\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
283.472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
898\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s acidic ribosomal protein p1. [source:swissprot;acc:p05386]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.171\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
238.048\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03874\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
899\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TXNDC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thioredoxin domain-containing 2; sperm-specific thioredoxin; thioredoxin domain-containing 2 (spermatozoa). [source:refseq;acc:nm\_032243]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TXN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thioredoxin (atl-derived factor) (adf) (surface associated sulphydryl protein) (sasp). [source:swissprot;acc:p10599]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/